Aparna Kasinath Email Address

Laboratory Head and GLP Test Facility Management

Syngene International Limited, (BSE code: 539268, NSE Id: SYNGENE, ISIN Id: INE398R01022) is one of Asia's largest Contract Research Organizations. It provides discovery and developmental services for new molecular entities across multiple platforms including Small Molecules, Large Molecules, Antibody-Drug Conjugates and Oligonucleotides. These services are aimed towards bringing novel molecules to the market by supporting the R&D efforts of organizations across diverse sectors like pharma, biotechnology, nutrition and animal health. Syngene offers an integrated platform for R&D focused organizations to optimize their R&D investments and develop their novel molecules with a distinctive cost advantage. In FY2016, Syngene serviced 256 clients including 8 of the top 10 global pharma companies. For more details, visit: www.syngeneintl.com.

Specialties: Leadership in Bioanalytical support & execution of contracted Novel Biologics and Biosimilar drug development programs Program Management and Scientific Business Development for PK and Immunogenicity assay support Immunoassay Development, Transfer/Validation for Immunogenicity & Pharmacokinetic of Biotherapeutics/Biosimilars. Cell based potency and Neutralizing antibody assay Development & Validation of Biotherapeutics/Biosimilars. Shake flask to pilot fermenter scale up for production of enzymes and downstream enzyme assay support. Laboratory automation of assays Trained in OECD Good Laboratory Practices - GLP Trained in WHO Good Clinical Laboratory Practices- GCLP